High magnetic field reduces side effects caused by anti-cancer drug imatinib

by Zhang Nannan,Chinese Academy of Sciences9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Credit: Ji XinmiaoResearchers led by Prof. Zhang Xin

Updated on: December 22,2023

High magnetic field reduces side effects caused by anti-cancer drug imatinib

by Zhang Nannan,Chinese Academy of Sciences9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Credit: Ji XinmiaoResearchers led by Prof. Zhang Xin

Updated on:December 22,2023

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6

Updated on: January 08,2024

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6

Updated on:January 08,2024

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on: February 20,2024

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on:February 20,2024

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Updated on: December 20,2023

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Updated on:December 20,2023

Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

by Lauren Nichola Colley,The ConversationCredit: Pixabay/CC0 Public DomainGoing for a walk is always a good idea. Perhaps, if you are lucky enough, this might be a hike along ragged cliffs or tr

Updated on: March 22,2024

Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

by Lauren Nichola Colley,The ConversationCredit: Pixabay/CC0 Public DomainGoing for a walk is always a good idea. Perhaps, if you are lucky enough, this might be a hike along ragged cliffs or tr

Updated on:March 22,2024

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Updated on: April 24,2024

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Updated on:April 24,2024

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s

Updated on: December 25,2023

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s

Updated on:December 25,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on: December 20,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on:December 20,2023

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on: March 14,2024

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA

Updated on:March 14,2024

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Updated on: December 18,2023

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Updated on:December 18,2023

Is this a faster, better treatment for blood and solid tumor cancers?

by Cynthia McCormick Hibbert,Northeastern UniversityCredit: Alyssa Stone/Northeastern UniversityA Northeastern researcher in the Department of Pharmaceutical Sciences and the New England Inflamm

Updated on: January 26,2024

Is this a faster, better treatment for blood and solid tumor cancers?

by Cynthia McCormick Hibbert,Northeastern UniversityCredit: Alyssa Stone/Northeastern UniversityA Northeastern researcher in the Department of Pharmaceutical Sciences and the New England Inflamm

Updated on:January 26,2024

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on: December 02,2024

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on:December 02,2024